SynthesisThoracic cancer2023

Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis.

Yu Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.